Adipose-Derived Stromal/Stem Cells (ASC) in Regenerative Medicine: Pharmaceutical Applications

Title: Adipose-Derived Stromal/Stem Cells (ASC) in Regenerative Medicine: Pharmaceutical Applications

Volume: 17 Issue: 4

Author(s): Jeffrey M. Gimble and Mark E. Nuttall

Affiliation:

Keywords: Adipose-derived stromal/stem cells, Cytokines, Exocrine, Homing, Immunomodulators, Immunosuppression, Paracrine, Pharmaceutical

Abstract: Information relating to the biology, culture expansion, and mechanisms relating to adipose-derived cells has advanced significantly in the past decade. Both the heterogeneous stromal vascular fraction (SVF) and more homogeneous adipose-derived stem cells (ASC) offer unique opportunities as novel cell-based therapeutics and as traditional pharmaceutical discovery tools. This review highlights the cytokine secretory functions of ASC and SVF cells as well as their potential use as immunomodulators and gene delivery vehicles. These functions make it feasible to exploit adipose-derived cells in the treatment of ischemic, musculoskeletal, and oncological disorders. With appropriate commercial development and in vivo validation, ASC and SVF cells will have a significant therapeutic impact in the future.

Cite this article as:

M. Gimble Jeffrey and E. Nuttall Mark, Adipose-Derived Stromal/Stem Cells (ASC) in Regenerative Medicine: Pharmaceutical Applications, Current Pharmaceutical Design 2011; 17 (4) . https://dx.doi.org/10.2174/138161211795164220